How does rhIL - 11 injection vial improve platelet count?
Hey there! As a supplier of rhIL - 11 injection vials, I'm super excited to share with you how these little vials can work wonders in improving platelet counts. So, let's dive right in!
Understanding Platelets and Their Importance
First off, let's talk about platelets. They're these tiny cell fragments in our blood, but don't let their size fool you. They play a crucial role in stopping bleeding. When we get a cut or an injury, platelets rush to the site and clump together to form a plug, which helps to stop the blood from flowing out. Without enough platelets, even a small cut can turn into a big problem.
Low platelet counts, or thrombocytopenia, can happen for various reasons. Chemotherapy and radiation therapy for cancer are common culprits. These treatments are great at killing cancer cells, but they can also damage the bone marrow, where platelets are made. Other causes include certain diseases like leukemia, autoimmune disorders, and some medications.
What is rhIL - 11?
rhIL - 11 stands for recombinant human interleukin - 11. It's a man - made version of a protein that our body naturally produces. Interleukins are part of our immune system's communication network. They help different cells in our body talk to each other and coordinate the immune response.
In the case of rhIL - 11, it acts on the bone marrow. The bone marrow is like a factory that produces all our blood cells, including platelets. rhIL - 11 stimulates the stem cells in the bone marrow to develop into megakaryocytes. Megakaryocytes are these large cells that eventually break apart to form platelets. So, by increasing the production of megakaryocytes, rhIL - 11 helps to boost the platelet count in our blood.
How rhIL - 11 Injection Vials Work
When a patient is given an injection of rhIL - 11 from our vials, the protein quickly gets into the bloodstream. It then travels to the bone marrow, where it binds to specific receptors on the surface of stem cells. This binding triggers a series of chemical reactions inside the cells, which tell them to start differentiating into megakaryocytes.
Over time, as more megakaryocytes are produced, they start to break down into platelets. This process takes a few days, but gradually, the platelet count in the blood starts to rise. It's like giving the bone marrow a little nudge to get back to work and make more platelets.
Benefits of Using rhIL - 11 Injection Vials
One of the biggest benefits is that it can reduce the need for platelet transfusions. Platelet transfusions are often used to quickly increase the platelet count in patients with severe thrombocytopenia. But they come with their own risks, like allergic reactions and the transmission of infections. By using rhIL - 11 injection vials, we can help the body produce its own platelets, which is a more natural and safer way.
Another benefit is that it can allow patients to continue with their cancer treatments. Chemotherapy and radiation therapy are usually paused when the platelet count gets too low. But with rhIL - 11, the platelet count can be maintained at a safe level, so patients can keep getting their treatments on schedule. This is crucial for the effectiveness of the cancer treatment.
Our rhIL - 11 Injection Vials
We offer rhIL - 11 injection vials in different strengths: 0.75mg/vial, 1.5mg/vial, and 3mg/vial. This allows doctors to choose the right dosage for each patient based on their specific needs. Our vials are made with high - quality standards, ensuring the purity and effectiveness of the rhIL - 11.
You can find more details about our RhIL - 11 Injection(Oprelvekin), CAS No.: 145941 - 26 - 0, (Recombinant Human Interleukin - 11) – A Drug To Increase Platelet Count, RhIL - 11 Injection Lyophilized Powder (vial): 0.75mg/vial, 1.5mg/vial, 3mg/vial on our website.
Other Related Products
In addition to our rhIL - 11 injection vials, we also have other products in the oncology injection category. For example, our Daratumumab Injection - Multiple Myeloma (CD - 38 Mab), CAS No.: 945721 - 28 - 8 is a great option for treating multiple myeloma. And our SIRPα - Specific Monoclonal Antibody is also showing promise in the field of oncology.
Real - Life Impact
I've heard so many stories from doctors and patients about how our rhIL - 11 injection vials have made a difference. One patient who was undergoing chemotherapy for breast cancer was really struggling with low platelet counts. She was having to get frequent platelet transfusions, which were making her feel weak and uncomfortable. After starting treatment with our rhIL - 11 injection vials, her platelet count started to improve. She was able to continue her chemotherapy without as many interruptions, and her overall quality of life got better.
Contact Us for Procurement
If you're interested in our rhIL - 11 injection vials or any of our other oncology injection products, we'd love to hear from you. Whether you're a hospital, a pharmacy, or a distributor, we can work together to meet your needs. Don't hesitate to reach out for more information and to start a procurement discussion.
References
- "The role of interleukin - 11 in hematopoiesis and immune regulation." Journal of Hematology & Oncology.
- "Recombinant human interleukin - 11 for the prevention of chemotherapy - induced thrombocytopenia." Cancer Treatment Reviews.
- "Clinical trials of rhIL - 11 in patients with thrombocytopenia." Blood.